Preclinical Efficacy Data of Apogenix' HERA-CD27L Published in Frontiers in Oncology — BioPortfolio.com
Bioportfolio,
DGAP-News: Apogenix AG / Key word(s): Scientific publication 02.10.2018 / 10:00 The issuer is solely responsible for the…
Preclinical Efficacy Data of Apogenix' HERA-CD27L
Direkt Broker ,
Published in Frontiers in Oncology HERA-CD27L Enhances T Cell Activation and Induces Anti-Tumor Immunity Heidelberg, Germany…
Apogenix AG,
Ad Hoc News,
Präklinische Daten zur Wirksamkeit von Apogenix' HERA-CD27L in Frontiers in Oncology veröffentlicht Präklinische Daten zur…